Corbus Stock Down as Lenabasum Fails to Meet Primary Endpoint
Shares of
Corbus Pharmaceuticals Holdings, Inc.
CRBP
fell 35.9% after it announced disappointing top-line results from its 28-week phase IIb study of lenabasum in patients with cystic fibrosis (CF). However, shares of the…
Biotech Stock Roundup: ALXN to Raise Guidance, BMY to Buy MYOK & Other Updates
It was a busy week for the biotech sector, with quite a few regulatory and other pipeline updates. While coronavirus-related news continues to grab headlines as President Trump tested positive, other regulatory events and pipeline news were also in…
Alexion Plans to Raise 2020 Sales View, Buy Back $3B Shares
Shares of
Alexion Pharmaceuticals, Inc
.
ALXN
gained after it announced that it plans to raise its annual guidance for 2020 by more than $200 million.
An update on the same will be provided by the company when it re…
Sky Solar Holdings, Ltd. Announces Striking Out of Winding-up Petition
HONG KONG, Oct. 07, 2020 (GLOBE NEWSWIRE) — Sky Solar Holdings, Ltd. (NASDAQ: SKYS) (“Sky Solar” or the “Company”), a global developer, owner and operator of solar parks, today announced that on October 6, 2020, the winding up petition (the…
Big Update from Avalon on Ontario Lithium Project
Avalon Advanced Materials Inc. (TSX: AVL, OTC: AVLNF, Forum) provided investors with an update on its Separation Rapids Lithium Project on Wednesday. Since the beginning of the summer, metallurgical test work had been progressing on several fronts to…
Registration Is Now Open For Atossa Therapeutics’ Tribe Public Webinar Presentation and Q&A Event On October 13, 2020
In honor of October Breast Cancer Awareness Month, Atossa’s CEO Dr. Steven Quay, M.D., Ph.D. & CFO Kyle Guse will deliver a presentation titled “Atossa Therapeutics: Tackling our Greatest Health Challenges – COVID-19 and Breast cancer”
SEATTLE…
CORRECTION: Amex Expands HGZ by over 275 metres to 1,100 metres Vertically and Reports Multiple High Grade Intercepts Including 14.07 g/t Au over 9.75 metres
The correction is to the title of the release, corrected to 14.07 g/t Au over 9.75 m, previously the Company stated 14.07 g/t over 8.75 m. In addition, Amex has made a correction to the interpretation of the HGZ paragraph.
MONTREAL, QC / ACCESSWIRE / O…
New Report Projects Immunotherapy Drug Market to Reach $274.6 Billion by 2025 with CAGR of 11.0%
A newly released report titled “Immunotherapy Drugs Market by Type, Therapy Area, End User – Global Forecast to 2025” forecasts the global immunotherapy drugs market to reach USD 274. 6 billion by 2025 from USD 163. 0 billion i…
Achieve Life Sciences Announces Start of Phase 3 ORCA-2 Clinical Trial Evaluating Cytisinicline for Smoking Cessation
ACHIEVE-LIFE-SCIENCES
Designed to Assess the Efficacy and Safety of 3 mg Cytisinicline Three Times Daily Dosing Compar…
5G Stocks: 3 Smaller Companies to Consider for Your Portfolio
Many things about 5G are controversial—but not its potential value as an investment. Whether you believe 5G will be the source of a new technological revolution or a global meltdown, its relevancy means it stands a good chance of making you a decent re…
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates TCMD, VXRT Investors, Encourages Investors with Losses to Contact Firm, Reminds of Critical Upcoming Deadlines
SAN FRANCISCO, CA / ACCESSWIRE / October 6, 2020 / Hagens Berman updates investors in the following publicly-traded companies and urges investors who have suffered significant losses to contact the firm. Further details about the cases, including upco…
Arvinas to Present at the 3rd Annual Targeted Protein Degradation Summit
NEW HAVEN, Conn., Oct. 06, 2020 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that John Houston, Ph.D., President…
3 Cheap Tech Stocks Under $10 to Buy Despite Volatility Fears
The S&P 500 has climbed 4% since September 23 to help claw back some of its early September losses. Wall Street has turned its attention to the election, which is only four weeks away and might have become more complicated by President Trump’s …
IGT and Scientific Games Joint Statement on Brazilian LOTEX Concession
IGT-SCI-GAMES-LOTEX
IGT and Scientific Games Joint Statement on Brazilian LOTEX Concession
PR Newswire
LONDON and LAS VEGAS, Oct. 6, 2020
LONDON
and
LAS VEGAS
,
Oct. 6, 202…
CytomX Therapeutics Announces the Planned Retirement of Chief Scientific Officer, W. Michael Kavanaugh, M.D.
Marcia
P.
Belvin, Ph.D., Promoted to Senior Vice President, Head of Research
Dr. Kavanaugh to
Join
CytomX
Scientific
Advisory Board
SOUTH SAN F…
Synchronoss Technologies Engages MKR Investor Relations, Inc.
BRIDGEWATER, N.J., Oct. 06, 2020 (GLOBE NEWSWIRE) —
Synchronoss Technologies, Inc.
(NASDAQ: SNCR), a global leader and innovator in cloud, messaging, digital and IoT platforms and products, today announced that it has engaged…
Arcutis Biotherapeutics Announces Closing of Public Offering and Concurrent Private Placement of Common Stock
WESTLAKE VILLAGE, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatol…
Eton Pharmaceuticals Submits New Drug Application to the FDA for Topiramate Oral Solution (ET-101)
– Application Submitted for the Treatment of Partial-Onset Seizures and Migraine
– Eton’s Patent-Pending Product Addresses Significant Unmet Need for a Liquid Formulation of Topiramate
– Topiramate Oral Solution is …
